Drug Profile
Montelukast oral dispersible film
Alternative Names: Montelukast Na film; Montelukast ODF; Montelukast PharmaFilm®Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator MonoSol Rx
- Developer Aquestive Therapeutics
- Class Acetates; Anti-inflammatories; Antiasthmatics; Antidementias; Bronchodilators; Neuroprotectants; Nootropics; Quinolines; Small molecules
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Allergic rhinitis; Asthma
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Allergic-rhinitis in USA (Transmucosal, Film)
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Asthma in USA (Transmucosal, Film)
- 20 Aug 2014 Clinical trials in Allergic rhinitis in USA (Transmucosal)